Tag: PHS 340B Drug Pricing Program

Welcome to the CiiTA, LLC company blog – your resource for judicious, topical information related to the PHS 340B Drug Pricing Program. At CiiTA, we believe 340B is a critical part of the United States’ healthcare safety net, and as it experiences unprecedented and relatively unchallenged growth, we labor to stay ahead of the curve so that we can continue to teach our clients what even they don’t know that they don’t know. Our portfolio of services and products are designed around sustaining the 340B Program while mitigating untoward behavior within the program.

CiiTA focuses exclusively on the manufacturer and their participation in the 340B Program. We are outspoken about protecting the 340B Program by making it sustainable and transparent. To that end, this blog will bring you all the news and emerging policies about the program. (Note: for more in-depth articles about the program, please consider subscribing to The Synapse, a subscription-based report published bi-monthly with additional updates targeting specific events and market needs related to a particular 340B Program topic.)